Healthcare Value Capital

Healthcare Value Capital as of Dec. 31, 2016

Portfolio Holdings for Healthcare Value Capital

Healthcare Value Capital holds 18 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 23.9 $22M 100k 223.53
DepoMed 11.6 $11M 600k 18.02
Gilead Sciences (GILD) 10.4 $9.7M 135k 71.62
Biosante Pharmaceuticals (ANIP) 9.7 $9.1M 150k 60.62
Pfizer (PFE) 8.7 $8.1M 250k 32.48
Noveliontherapeuti.. 7.5 $7.0M 831k 8.42
Albany Molecular Research 6.1 $5.7M 302k 18.76
Amgen (AMGN) 3.9 $3.7M 25k 146.20
Allergan 3.4 $3.2M 15k 210.00
CryoLife (AORT) 3.1 $2.9M 150k 19.15
Teva Pharmaceutical Industries (TEVA) 2.9 $2.7M 75k 36.25
Aralez Pharmaceuticals 2.7 $2.5M 575k 4.41
Proshares Tr ultsh nasd biot 1.9 $1.8M 50k 35.00
Proshares Vix Short Term Futur 1.7 $1.6M 75k 21.27
Amarin Corporation (AMRN) 1.5 $1.4M 450k 3.08
Sunesis Pharmaceuticals Inc Ne 0.6 $543k 150k 3.62
Zogenix 0.4 $387k 32k 12.15
Fibrocell Science 0.0 $30k 48k 0.63